Spire Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$9.01K 2230
2024
Q1
$9.01K Hold
500
﹤0.01% 1745
2023
Q4
$9.1K Hold
500
﹤0.01% 1785
2023
Q3
$9.93K Hold
500
﹤0.01% 1731
2023
Q2
$9.38K Hold
500
﹤0.01% 1839
2023
Q1
$10.2K Hold
500
﹤0.01% 1834
2022
Q4
$11K Hold
500
﹤0.01% 1565
2022
Q3
$10K Buy
+500
New +$9.96K ﹤0.01% 1558

Other funds holding BTAL

Spire Wealth Management's BTAL Position: Q2 2024 in Review

Spire Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2024, closing a stake of 500 shares — an estimated $9.01K sold.

Spire Wealth Management first reported a position in BTAL in Q3 2022 and held it in 7 quarters. The position peaked at $11K in Q4 2022. 59 funds tracked by Wall St. Rank hold BTAL as of Q2 2024.

  • Spire Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2024 after selling out during the quarter.
  • Spire Wealth Management sold 500 AGF US Market Neutral Anti-Beta Fund shares in Q2 2024, an estimated $9.01K.
  • Spire Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 7 quarters.
  • Spire Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $11K in Q4 2022.
  • 59 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2024.

Based on Spire Wealth Management's 13F filing for Q2 2024, filed 31 Jul 2024.